| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |